Aim: The study's goal is to assess the impact of coblation on minimising adenoidectomy discomfort and morbidity. Material and methods: The ENT department performed this retrospective observational analysis. The study included 100 young people who underwent coblation adenoidectomy. A 0° endoscope was passed after nasal decongestion with 4% xylocaine and adrenaline solution. The adenoids and nasal cavity were examined. A Boyle Davis mouth gag was employed, as well as Coblation technology with ProciseTM XP or ProciseTM MAX tips, to remove adenoid tissue and achieve hemostasis at the same time. Results: Patients' pre-operative symptoms of disrupted sleep are compared to their postoperative sleep. All 100 patients had disrupted sleep before surgery; however, only 13 experienced disturbed sleep in the early post-operative period, while the other 87 had pleasant sleep. Post-operative discomfort following coblation adenoidectomy was assessed both immediately after surgery and one week later. 75% of patients reported no pain in the immediate post-operative period, and 91% reported no discomfort when they returned to the hospital for the first time one week following surgery. In our study, we counted the number of upper respiratory infections that occurred after coblation adenoidectomy. Within the first year, 71 (71%) of patients had no episodes of nasopharyngeal infection. Within the first year, 29 individuals (29%) developed infections. Conclusion: We conclude that the endoscopic assisted coblation adenoidectomy is a safe and effective method of adenoidectomy.